Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
Zhang W, Konopleva M, Shi YX, McQueen T, Harris D, Ling X, Estrov Z, Quintás-Cardama A, Small D, Cortes J, Andreeff M.
Zhang W, et al. Among authors: andreeff m.
J Natl Cancer Inst. 2008 Feb 6;100(3):184-98. doi: 10.1093/jnci/djm328. Epub 2008 Jan 29.
J Natl Cancer Inst. 2008.
PMID: 18230792
Clinical Trial.